Medifast, Inc.
MED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $192,587 | $731,622 | $1,291,343 | $2,451,378 |
| - Cash | $90,928 | $94,440 | $87,691 | $104,183 |
| + Debt | $16,125 | $22,012 | $26,051 | $32,543 |
| Enterprise Value | $117,784 | $659,194 | $1,229,703 | $2,379,738 |
| Revenue | $602,463 | $1,072,054 | $1,598,577 | $1,526,087 |
| % Growth | -43.8% | -32.9% | 4.8% | – |
| Gross Profit | $444,623 | $775,850 | $1,140,414 | $1,127,597 |
| % Margin | 73.8% | 72.4% | 71.3% | 73.9% |
| EBITDA | $15,585 | $139,509 | $195,740 | $223,053 |
| % Margin | 2.6% | 13% | 12.2% | 14.6% |
| Net Income | $2,091 | $99,415 | $143,568 | $164,031 |
| % Margin | 0.3% | 9.3% | 9% | 10.7% |
| EPS Diluted | 0.19 | 9.1 | 12.73 | 13.89 |
| % Growth | -97.9% | -28.5% | -8.4% | – |
| Operating Cash Flow | $24,476 | $147,657 | $194,570 | $94,545 |
| Capital Expenditures | -$7,454 | -$6,483 | -$16,681 | -$34,209 |
| Free Cash Flow | $17,022 | $141,174 | $177,889 | $60,336 |